{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:33:46Z","timestamp":1773146026001,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/rhu.0b013e3182320680","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:39:46Z","timestamp":1356003586000},"page":"373-376","source":"Crossref","is-referenced-by-count":9,"title":["Clarithromycin in Adult-Onset Still's Disease"],"prefix":"10.1097","volume":"17","author":[{"given":"Aikaterini","family":"Thanou-Stavraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Aberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara L.","family":"Bane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Harley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210207","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncprheum0510","article-title":"Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?","volume":"3","author":"Efthimiou","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R2-8-20210207","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol Ther"},{"key":"R3-8-20210207","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"R4-8-20210207","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3899\/jrheum.090316","article-title":"Functional association of interleukin 18 gene -607 (C\/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease.","volume":"36","author":"Chen","year":"2009","journal-title":"J Rheumatol"},{"key":"R5-8-20210207","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective.","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"R6-8-20210207","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1067\/mjd.2001.117525","article-title":"Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.","volume":"45","author":"Bornhovd","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R7-8-20210207","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics.","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-8-20210207","first-page":"1765","article-title":"Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.","volume":"32","author":"Urasaki","year":"2005","journal-title":"J Rheumatol"},{"key":"R9-8-20210207","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1081-1206(10)62264-8","article-title":"Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study.","volume":"87","author":"Spahn","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R10-8-20210207","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70175-2","article-title":"Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy.","volume":"103","author":"Fost","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"R11-8-20210207","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases.","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"key":"R12-8-20210207","first-page":"373","article-title":"Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study.","volume":"20","author":"Saviola","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"R13-8-20210207","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1185\/030079906X167642","article-title":"Effects of clarithromycin in patients with active rheumatoid arthritis.","volume":"23","author":"Ogrendik","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R14-8-20210207","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.clinthera.2009.08.014","article-title":"Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.","volume":"31","author":"Ogrendik","year":"2009","journal-title":"Clin Ther"},{"key":"R15-8-20210207","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semarthrit.2006.04.005","article-title":"Open-label study of clarithromycin in patients with undifferentiated connective tissue disease.","volume":"36","author":"Moskowitz","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R16-8-20210207","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00296-009-1277-9","article-title":"Clarithromycin in adult-onset Still's disease: a study of 6 cases.","volume":"30","author":"Saviola","year":"2010","journal-title":"Rheumatol Int"},{"key":"R17-8-20210207","first-page":"379","article-title":"Clarithromycin in adult-onset Still's disease. Case report with a 1-year follow-up.","volume":"22","author":"Saviola","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R18-8-20210207","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R19-8-20210207","first-page":"330","article-title":"Successful treatment of a patient with refractory adult-onset Still disease with anakinra.","volume":"9","author":"Rudinskaya","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"R20-8-20210207","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R21-8-20210207","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase III trial.","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"R22-8-20210207","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10067-010-1553-9","article-title":"A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.","volume":"29","author":"Perdan-Pirkmajer","year":"2010","journal-title":"Clin Rheumatol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e3182320680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:06:16Z","timestamp":1745463976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201110000-00008"}},"subtitle":["A Potentially Useful Therapeutic"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3182320680","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}